You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
龍虎榜 | 二六三漲停,獲淨買入1.14億元;兔寶寶跳水,孫哥賣出2754萬元

1月12日,兩市共有近2912只股票上漲,超1900只股票下跌。其中,有438只漲停股,10只跌停股。北上資金再度大幅淨買入A股133.36億元,創2022年11月以來新高,已連續8日做多A股。

盤面上,資金聚焦數字經濟、汽車零部件、儲能等板塊,高位股方面,數字經濟板塊天威視訊4板,醫美+嬰童的金髮拉比3板,軍工股通達股份2板,電子紙概念股合力泰2板,充電樁板塊泰永長征2板。

下面我們來看下今日龍虎榜情況:

龍虎榜淨買入額前三為二六三、盈方微、亞虹醫藥(3日),分別為1.14億元、1.08億元、8266萬元。

龍虎榜淨賣出額前三為英飛拓、首創證券、黑芝麻,分別為1.3億元、9372萬元、8392萬元。

在龍虎榜中,涉及機構專用席位的個股淨買入額前三的是亞虹醫藥、百利天恆、羅曼股份,分別為2.22億元、6999萬元、2085萬元。

龍虎榜中涉及機構專用席位的個股中,當日淨賣出額前三為兔寶寶、東尼電子、黑芝麻,分別為7790萬元、6197萬元、5393萬元。

亞虹醫藥關注點:

公司股價連續三日放量上漲,均未漲停,今日股價收報14.42元,漲跌幅14.26%,換手率13.69%,成交額4.45億元。

1、亞虹醫藥是一家專注於泌尿生殖系統腫瘤及其它重大疾病領域的全球化創新藥公司。

2、亞虹醫藥於1月9日解禁1.27億股,佔總股本比例22.30%,解禁比例較大,解禁股類型是首發原股東限售股份。

百利天恆關注點:

公司股價走高,今日漲16.75%,報48.45元/股,總市值194.3億元

1、百利天恆1月6日上市,已自主研發了16個創新生物藥,涵蓋8個創新型雙/多抗體類在研項目、7個ADC在研項目和1個融合蛋白在研項目,這其中已有9個品種進入臨牀階段,且有5個為全球獨家品種。

2、公司預計全年度營業收入為68800萬元至72400萬元,同比減少13.65%至9.13%,預計歸屬於母公司股東的淨利潤為-32300萬元至-30300萬元,同比減少223.03%至203.03%。

羅曼股份關注點:

 公司股價經過三日快速上攻後,近兩日平台震盪,今日漲4.68%,報29.99元/股,總市值32.49億元。

1、公司的主營業務為景觀照明整體規劃和深化設計、景觀照明工程的施工以及遠程集控管理等景觀照明其他服務。

2、發佈澄清公吿,稱不涉及新能源汽車業務,未涉及其他媒體報道、市場傳聞或市場熱點概念。

機構關注個股:

亞虹醫藥:3機構淨買入2.22億元

百利天恆:4機構買入7730萬元,1機構賣出731萬元,淨買入6999萬元

羅曼股份:1機構淨買入2085萬元

曲美家居:1機構買入2607萬元,1機構賣出733萬元,淨買入1874萬元

好上好:2機構淨買入1487萬元

在龍虎榜中,涉及滬股通專用席位的個股為金牌櫥櫃、中航產融,分別獲淨買入43萬元、淨賣出1957萬元。

在龍虎榜中,涉及深股通專用席位的個股有3只,兔寶寶的深股通專用席位淨買入額最大,淨買入3670萬元。

遊資操作動向:

孫哥:淨買入二六三9790萬元,淨賣出兔寶寶2754萬元

趙老哥:淨賣出通達動力794萬元

益田路:淨賣出安奈兒1744萬元

徐留勝:淨買入貴航股份948萬元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account